The era of histoplasmosis in Brazilian endemic mycoses
- PMID: 36777401
- PMCID: PMC9903817
- DOI: 10.1016/j.lana.2021.100037
The era of histoplasmosis in Brazilian endemic mycoses
Conflict of interest statement
DRF has received speaker honoraria on behalf of Gilead, United Medical, MSD, and Pfizer. He has participated in the safety advisory board of GSK and received research material from IMMY. DFDL has no conflict of interest to declare. ACP has consulted and/or given paid talks for Gilead, IMMY, United Medical, Pfizer, Teva and MSD, as well as received research grants from Gilead, and research material from IMMY.
Figures
References
-
- Queiroz-Telles F, Fahal AH, Falci DR, Caceres DH, Chiller T, Pasqualotto AC. Neglected endemic mycoses. The Lancet Infectious diseases. 2017;17(11):e367–ee77. - PubMed
-
- Cáceres DH, Samayoa BE, Medina NG, Tobón AM, Guzmán BJ, Mercado D, et al. Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries. Journal of clinical microbiology. 2018;56(6) - PMC - PubMed
-
- Cáceres DH, Gómez BL, Tobón AM, Chiller TM, Lindsley MD. Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS. Mycoses. 2020;63(2):139–144. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
